A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2016-02-11
- Lead Sponsor
- Deacon Biosciences, Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT01853722
- Locations
- 🇺🇸
Andover Eye Associates, Andover, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath